Johns Hopkins ABX Guide
Cefazolin
Cefazolin is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Respiratory tract infections
- Due to S. pneumoniae, S. aureus (MSSA) and S. pyogenes
- Urinary tract infections
- Due to E. coli, P. mirabilis
- Prostatitis and epididymitis
- Due to E. coli, PP. mirabilis
- Skin and skin structure infections
- Due to S. aureus (MSSA), S. pyogenes, and other strains of streptococci
- Biliary tract infections
- Due to E. coli, various strains of streptococci, P. mirabilis, and S. aureus (MSSA)
- Bone and joint infections due to S. aureus (MSSA)
- Septicemia
- Due to S. pneumoniae, S. aureus (MSSA), P. mirabilis, E. coli
- Endocarditis
- Due to S. aureus (MSSA) and S. pyogenes
- Perioperative prophylaxis
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Parotitis (MSSA)
- Other Staphylococcus aureus (MSSA) infections
- Other Streptococcus pyogenes (Group A) infections
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Respiratory tract infections
- Due to S. pneumoniae, S. aureus (MSSA) and S. pyogenes
- Urinary tract infections
- Due to E. coli, P. mirabilis
- Prostatitis and epididymitis
- Due to E. coli, PP. mirabilis
- Skin and skin structure infections
- Due to S. aureus (MSSA), S. pyogenes, and other strains of streptococci
- Biliary tract infections
- Due to E. coli, various strains of streptococci, P. mirabilis, and S. aureus (MSSA)
- Bone and joint infections due to S. aureus (MSSA)
- Septicemia
- Due to S. pneumoniae, S. aureus (MSSA), P. mirabilis, E. coli
- Endocarditis
- Due to S. aureus (MSSA) and S. pyogenes
- Perioperative prophylaxis
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Parotitis (MSSA)
- Other Staphylococcus aureus (MSSA) infections
- Other Streptococcus pyogenes (Group A) infections
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 18, 2022
Citation
Auwaerter, Paul G, and Edina Avdic. "Cefazolin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2022. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540087/7/Cefazolin.
Auwaerter PG, Avdic E. Cefazolin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540087/7/Cefazolin. Accessed April 1, 2023.
Auwaerter, P. G., & Avdic, E. (2022). Cefazolin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540087/7/Cefazolin
Auwaerter PG, Avdic E. Cefazolin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. [cited 2023 April 01]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540087/7/Cefazolin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cefazolin
ID - 540087
A1 - Auwaerter,Paul,M.D.
AU - Avdic,Edina,Pharm.D.
Y1 - 2022/10/18/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540087/7/Cefazolin
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
